These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 31980023)

  • 21. Benchtop technologies for circulating tumor cells separation based on biophysical properties.
    Low WS; Wan Abas WA
    Biomed Res Int; 2015; 2015():239362. PubMed ID: 25977918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots.
    Kuo CW; Chueh DY; Chen P
    J Nanobiotechnology; 2019 Feb; 17(1):26. PubMed ID: 30728024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells.
    Chen JY; Chang YC
    Adv Exp Med Biol; 2017; 994():43-66. PubMed ID: 28560667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of rare circulating tumour cells in cancer patients by microchip technology.
    Nagrath S; Sequist LV; Maheswaran S; Bell DW; Irimia D; Ulkus L; Smith MR; Kwak EL; Digumarthy S; Muzikansky A; Ryan P; Balis UJ; Tompkins RG; Haber DA; Toner M
    Nature; 2007 Dec; 450(7173):1235-9. PubMed ID: 18097410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor cells as a promising target for individualized drug susceptibility tests in cancer therapy.
    Smit DJ; Pantel K; Jücker M
    Biochem Pharmacol; 2021 Jun; 188():114589. PubMed ID: 33932470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival Mechanisms and Influence Factors of Circulating Tumor Cells.
    Wang WC; Zhang XF; Peng J; Li XF; Wang AL; Bie YQ; Shi LH; Lin MB; Zhang XF
    Biomed Res Int; 2018; 2018():6304701. PubMed ID: 30515411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into the correlations between circulating tumor cells and target organ metastasis.
    Zhan Q; Liu B; Situ X; Luo Y; Fu T; Wang Y; Xie Z; Ren L; Zhu Y; He W; Ke Z
    Signal Transduct Target Ther; 2023 Dec; 8(1):465. PubMed ID: 38129401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Tumor Cell Clusters: United We Stand Divided We Fall.
    Amintas S; Bedel A; Moreau-Gaudry F; Boutin J; Buscail L; Merlio JP; Vendrely V; Dabernat S; Buscail E
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells.
    Menyailo ME; Bokova UA; Ivanyuk EE; Khozyainova AA; Denisov EV
    Mol Diagn Ther; 2021 Sep; 25(5):549-562. PubMed ID: 34287797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NK cells-directed therapies target circulating tumor cells and metastasis.
    Dianat-Moghadam H; Mahari A; Heidarifard M; Parnianfard N; Pourmousavi-Kh L; Rahbarghazi R; Amoozgar Z
    Cancer Lett; 2021 Jan; 497():41-53. PubMed ID: 32987138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of CTC Clusters in Breast Cancer Metastasis.
    Piñeiro R; Martínez-Pena I; López-López R
    Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.
    Guibert N; Delaunay M; Lusque A; Boubekeur N; Rouquette I; Clermont E; Mourlanette J; Gouin S; Dormoy I; Favre G; Mazieres J; Pradines A
    Lung Cancer; 2018 Jun; 120():108-112. PubMed ID: 29748004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Molecular Voyage: Multiomics Insights into Circulating Tumor Cells.
    Zhang YW; Gvozdenovic A; Aceto N
    Cancer Discov; 2024 Jun; 14(6):920-933. PubMed ID: 38581442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor cells: clinical validity and utility.
    Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
    Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking cancer progression: from circulating tumor cells to metastasis.
    Castro-Giner F; Aceto N
    Genome Med; 2020 Mar; 12(1):31. PubMed ID: 32192534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative diagnosis of cancer by combining CTCs and associated peripheral blood cells in liquid biopsy.
    Zhang WW; Rong Y; Liu Q; Luo CL; Zhang Y; Wang FB
    Clin Transl Oncol; 2019 Jul; 21(7):828-835. PubMed ID: 30569214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
    Hu B; Tian X; Li Y; Liu Y; Yang T; Han Z; An J; Kong L; Li Y
    Cancer Med; 2020 Apr; 9(8):2686-2697. PubMed ID: 32077634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.